The Florida Melanoma Trial I: A Prospective Multicenter Phase I/II Trial of Postoperative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-Alfa-2b in the Treatment of Advanced Stage III Melanoma with Long-Term Toxicity Follow-Up

Table 6

Patterns of failure among all evaluable patients (𝑛=23).

	Number	%
NED overall	7	30.4
In-field failure only	3	13.0
In-field + distant	1	4.3
Out-field failure only	0	0
Out-field + distant	0	0
Distant failure only	11	47.8
Unknown status	1	4.3
Regional control	18	78.3
Regional recurrence	5	21.7
TOTAL	23	100